Table 2 List of cell surface markers used in this study
From: An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides
Antibody | Source | Catalog no. | Cell type marker |
|---|---|---|---|
CD11b-APC | BioLegend | 101,212 | Macrophage |
CD11c-Pacific Blue | BioLegend | 117,322 | Myeloid Cell, DC |
CD11c-VioBlue | Miltenyi | 130-102-797 | Myeloid Cell, DC |
CD3ε-VioBlue | Miltenyi | 130-102-203 | T Cell |
CD4-APC | BioLegend | 100,412 | TH Cell |
CD8α-PE | BioLegend | 100,708 | Cytotoxic T Cell |
CD19-FITC | BioLegend | 115,506 | B Cell |
CD69-FITC | BioLegend | 104,505 | Cell Activation |
CD73-Brilliant Violet | BioLegend | 127,215 | B Memory Cell |
CD80-APC | BioLegend | 104,713 | B Cell Activation |
CD86-APC | BioLegend | 105,011 | Cell Activation |
CD273-PE | BioLegend | 107,205 | B Memory Cell |
F4/80-PE | BioLegend | 123,110 | Macrophage |
Ly6C-FITC | Miltenyi | 130-093-134 | Monocyte |
NK1.1-APC | Miltenyi | 130-095-869 | NK Cell |